<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03714750</url>
  </required_header>
  <id_info>
    <org_study_id>TIP TAP I</org_study_id>
    <nct_id>NCT03714750</nct_id>
  </id_info>
  <brief_title>Treatment of Coronary Bifurcation Lesions: Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting</brief_title>
  <acronym>TIPTAP-I</acronym>
  <official_title>Treatment of Coronary Bifurcation Lesions: a Non-inferiority, Randomized, Controlled Procedural Outcomes Trial Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tommaso Gori</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of bifurcation coronary lesions may be challenging, and the best technique to be&#xD;
      used in these settings remains to be established. While a single stent strategy is simpler&#xD;
      and has been often encouraged, a number of studies show that the use of modern stent&#xD;
      implantation techniques may bring some advantages in terms of target lesion failure during&#xD;
      longer follow-up. Further, single-stent procedures are not possible at all in some settings,&#xD;
      for instance when both main and side branch have similar diameters and present both relevant&#xD;
      disease, particularly when the angle between the vessels is lower than 70Â°. Recent randomized&#xD;
      data demonstrate the superiority of the technique called double kissing and crush (DK-Crush)&#xD;
      over provisional stenting in this setting. The DK-Crush technique is however cumbersome,&#xD;
      time-consuming and requires very experienced operators. The investigators therefore plan to&#xD;
      undertake a randomized study comparing a novel interventional technique against DK-crush in&#xD;
      the setting of true bifurcation lesions (Medina lesions type 1,1,1 or 0,1,1).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stent Expansion in the side branch (defined as the vessel which received the first stent)</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Ratio of the minimum stent area of the side branch and the maximum stent area of the side branch</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fluoroscopy time</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Time of radiation during intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedural time</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>time of procedure (&quot;Skin-to-Skin&quot;-time)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of coronary wires</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>amount of coronary wires used during procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>protocol success</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>the Intervention is performed according to the protocol (including final kissing PTCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Min. lumen Diameter in main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Minimum lumen Diameter in the main branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Stenosis in main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Percentage of Stenosis in the main branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Min. lumen Diameter in side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Minimum lumen Diameter in the side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Stenosis in side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>Percentage of Stenosis in the side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>through study completion, an average of 2 days</time_frame>
    <description>procedural success defined by angiographic success (no residual Stenosis of more than 20% at the end of Radiation) AND no periprocedural complications (including STEMI, new Q-wave myocardial infarction (MI), death, stent thrombosis, by-pass surgery, peri-procedural cardiac biomarker release according to the third universal definition of myocardial infarction) at discharge</description>
  </secondary_outcome>
  <other_outcome>
    <measure>average stent eccentricity index (SEI) in the side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, calculated as the Ratio of the Minimum to Maximum stent Diameter in the side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>average stent eccentricity index (SEI) in the main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, calculated as the Ratio of the Minimum to Maximum stent Diameter in the main branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Minimum lumen diameter in the main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Minimum lumen Diameter in the main branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean lumen diameter in the main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Mean lumen Diameter in the main branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Minimum lumen area in the main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Minimum lumen Area in the main branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean lumen area in the main branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Mean lumen Area in the main branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Minimum lumen diameter in the side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Minimum lumen Diameter in the side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean lumen diameter in the side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Mean lumen Diameter in the side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Minimum lumen area in the side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Minimum lumen area in the side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean lumen area in the side branch</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, Mean lumen Area in the side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Side branch obstruction</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, side branch obstruction through malapposed struts expressed as mean ratio between maximum inter-strut opening and side branch ostium diameter</description>
  </other_outcome>
  <other_outcome>
    <measure>Strut malapposition at bifurcation</measure>
    <time_frame>through study completion, an average of 2 hours</time_frame>
    <description>optical coherence tomography endpoint, % struts malapposed</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>DK crush</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous revascularization of true coronary bifurcation stenosis (Medina 1,1,1 or 0,1,1) with double kissing and crush technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reverse TAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous revascularization of true coronary bifurcation Stenosis (Medina 1,1,1 or 0,1,1) with reverse T and protrusion technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DK crush</intervention_name>
    <description>revascularization of true coronary bifurcation stenosis in DK crush technique</description>
    <arm_group_label>DK crush</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reverse TAP</intervention_name>
    <description>revascularization of true coronary bifurcation stenosis in Reverse TAP technique</description>
    <arm_group_label>Reverse TAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients must meet all of the inclusion criteria:&#xD;
&#xD;
          -  Documented heart team (as per guidelines) decision for revascularization via PCI&#xD;
&#xD;
          -  Planned percutaneous coronary intervention (PCI) for a bifurcation stenosis with both&#xD;
             branches &gt;2.5mm and with a stenosis &gt;50% and clinical indication to percutaneous&#xD;
             intervention, including:&#xD;
&#xD;
               -  Ischemic symptoms, OR&#xD;
&#xD;
               -  Positive non-invasive imaging for ischemia, OR&#xD;
&#xD;
               -  Positive Flow Fractional Reserve (FFR), OR&#xD;
&#xD;
               -  mean lumen area (MLA) &lt;6mm^2 for the left main or &lt;4mm^2 for epicardial vessels&#xD;
                  as assessed by intracoronary imaging (IVUS, OCT)&#xD;
&#xD;
          -  Vessel diameter â¤5.00mm&#xD;
&#xD;
          -  True bifurcation lesion type 1,1,1 or 0,1,1&#xD;
&#xD;
          -  Patient â¥18 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiogenic shock&#xD;
&#xD;
          -  Trifurcation if all vessels are â¥2.75mm diameter&#xD;
&#xD;
          -  Either bifurcation vessel not suitable for stenting&#xD;
&#xD;
          -  History of stenting in target bifurcation lesion&#xD;
&#xD;
          -  Participation in another investigational drug or device study&#xD;
&#xD;
          -  Patient unable to give informed consent&#xD;
&#xD;
          -  Women of child-bearing potential or lactating&#xD;
&#xD;
          -  In-stent restenosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Cardiology, Cardiology I, University hospital Mainz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
    <phone>+49 (0) 6131 17 2729</phone>
    <email>tommaso.gori@unimedizin-mainz.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center of Cardiology, Cardiology I, university hospital Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
      <phone>+49 (0) 6131 17 2729</phone>
      <email>tommaso.gori@unimedizin-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 4, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2018</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Tommaso Gori</investigator_full_name>
    <investigator_title>Prof. Dr. Tommaso Gori, PhD</investigator_title>
  </responsible_party>
  <keyword>bifurcation coronary lesions</keyword>
  <keyword>interventional technique of coronary lesions</keyword>
  <keyword>Double kissing and crush</keyword>
  <keyword>DK crush</keyword>
  <keyword>Reverse TAP</keyword>
  <keyword>reverse T-and-protrusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

